DOJ reschedules some marijuana products as Schedule III drugs

Washington — The Justice Department announced Thursday that it has issued an bid rescheduling definite marijuana products to a little cause classification.

The order was signed by Acting Attorney General Todd Blanche and placed FDA-approved products containing marijuana and products regulated by a authorities aesculapian marijuana licence successful Schedule III of the Controlled Substances Act. 

"The Department of Justice is delivering connected President Trump's committedness to grow Americans' entree to aesculapian attraction options," Blanche said successful a statement. "This rescheduling enactment allows for probe connected the information and efficacy of this substance, yet providing patients with amended attraction and doctors with much reliable information."

The determination by the Justice Department follows an executive bid signed by Mr. Trump successful December that directed the lawyer wide to statesman the rulemaking process to reschedule marijuana to Schedule III.

This is simply a breaking quality communicative and volition beryllium updated.